
Active Medical Group,
Tirzepatide is a dual incretin receptor agonist that works by mimicking the actions of two hormones involved in regulating blood sugar levels and appetite: GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide).
These hormones are naturally produced by the gut in response to eating and play key roles in managing blood sugar, fat metabolism, and energy balance. Tirzepatide is particularly innovative because it acts on both of these pathways, amplifying their effects, which makes it highly effective in managing type 2 diabetes and promoting weight loss.
Tirzepatide has shown impressive results in clinical trials. In studies like the SURMOUNT-1 trial, individuals using tirzepatide for weight loss (without diabetes) lost up to 20% of their body weight over a period of 72 weeks, depending on the dose. For comparison, this level of weight reduction is similar to what’s observed with some bariatric surgeries. Those using tirzepatide typically experienced more weight loss than with other GLP-1 receptor agonists like semaglutide.
Weight loss isn’t just about seeing the numbers drop on the scale but about building and preserving lean muscle mass to maintain a healthy metabolism. Muscle facilitates burning calories efficiently, supporting insulin sensitivity, and preventing the loss of strength often associated with rapid weight reduction.
Pairing Tirzepatide with a strength training program enhances weight loss outcomes, ensuring that you don’t just lose weight—but sculpt a stronger, healthier body.
Many underestimate the role of sleep in weight loss. Poor sleep leads to hormonal imbalances that increase hunger, slow metabolism, and cause fat storage—especially in the abdominal area.
Achieve optimal health and vitality with our personalized weight loss and hormone therapy solutions.